Raras
Buscar doenças, sintomas, genes...
Síndrome Pearson
ORPHA:699CID-10 · D64.0CID-11 · 3A72.01OMIM 557000DOENÇA RARA

A síndrome de Pearson é caracterizada por anemia sideroblástica refratária, vacuolização dos precursores da medula óssea e disfunção pancreática exócrina.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Pearson é caracterizada por anemia sideroblástica refratária, vacuolização dos precursores da medula óssea e disfunção pancreática exócrina.

Pesquisas ativas
2 ensaios
7 total registrados no ClinicalTrials.gov
Publicações científicas
171 artigos
Último publicado: 2026 Mar 23
Medicamentos
1 registrados
VATIQUINONE

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
VATIQUINONE

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.004
Worldwide
Casos conhecidos
194
pacientes catalogados
Início
Childhood
+ infancy, neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D64.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
12 sintomas
📏
Crescimento
9 sintomas
🩸
Sangue
7 sintomas
🧠
Neurológico
7 sintomas
🫘
Rins
5 sintomas
👁️
Olhos
5 sintomas

+ 39 sintomas em outras categorias

Características mais comuns

100%prev.
Atraso no desenvolvimento motor
Obrigatório (100%)
100%prev.
Síndrome de Fanconi renal
Obrigatório (100%)
100%prev.
Acidose metabólica
Frequência: 5/5
100%prev.
Anemia hipoplásica
Obrigatório (100%)
100%prev.
Acidúria 3-metilglutárica
Frequência: 4/4
100%prev.
Acidúria orgânica complexa
Obrigatório (100%)
96sintomas
Muito frequente (16)
Frequente (27)
Ocasional (40)
Muito raro (10)
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 96 características clínicas mais associadas, ordenadas por frequência.

Atraso no desenvolvimento motorHP:0003819
Obrigatório (100%)100%
Síndrome de Fanconi renalRenal Fanconi syndrome
Obrigatório (100%)100%
Acidose metabólicaMetabolic acidosis
Frequência: 5/5100%
Anemia hipoplásicaHypoplastic anemia
Obrigatório (100%)100%
Acidúria 3-metilglutárica3-Methylglutaric aciduria
Frequência: 4/4100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico171PubMed
Últimos 10 anos80publicações
Pico202313 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 24
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Pearson

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

7 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
81 papers (10 anos)
#1

Genotype-Phenotype Correlations in Chinese Pediatric Patients With Single Large-Scale Mitochondrial DNA Deletion Disorders.

Clinical genetics2026 Apr

This study investigated clinical and genetic characteristics of Chinese pediatric patients with single large-scale mitochondrial DNA deletions (SLSMD). We analyzed 28 patients (July 2004-March 2025) using long-range PCR and next-generation sequencing. Spearman correlation and ANOVA assessed genotype-phenotype relationships. Patients (mean age 5.52 ± 3.96 years) exhibited multi-organ involvement (5.43 ± 1.87 organs). Common initial presentations included ocular (29%), neurologic, and endocrine dysfunction. Only 14.3% had the classic 4977 bp deletion, and 23 novel deletions were identified in 25 patients. Larger deletions correlated with more deleted MRC complexes (r = 0.516, p = 0.0123) and more deleted tRNAs (r = 0.534, p = 0.0103). Kearns-Sayre syndrome (KSS) patients had later onset (p = 0.0337), larger deletions (p = 0.0263), and greater tRNA/MRC complex (p = 0.0263, p = 0.0319) involvement than non-KSS patients. SLSMD in Chinese children primarily causes KSS, Pearson syndrome (PS), and progressive ophthalmoplegia with multi-organ involvement. Genotype-phenotype correlations exist, particularly between deletion size, onset age, and disease severity. KSS patients show distinct genetic and clinical profiles, suggesting slower progression. This study expands the known SLSMD spectrum and underscores mitochondrial testing in pediatric multi-organ disorders.

#2

Pearson Syndrome: Diagnostic Challenges and a Case of Successful Haploidentical Hematopoietic Stem Cell Transplantation.

Pediatric blood &amp; cancer2026 Mar 23
#3

Single large-scale mitochondrial DNA deletion syndromes: scientific and family conference optimizes the collection of rare disease research outcomes.

Orphanet journal of rare diseases2025 Aug 04

The SLSMDS Research Network is a collaborative network comprising patient advocates, researchers, clinicians, and affected families seeking to improve outcomes for individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS). Building off of jointly developed research infrastructures, including a patient registry and natural history study, advocates and clinicians cohosted the SLSMDS Family and Scientific Conference, enabling the collection of patient data from an ultra-rare and geographically dispersed patient population. Here we describe the data collection procedures for single-time point laboratory assessments and patient reported outcomes for a subset of individuals with SLSMDS. Utilizing a reproducible model of rare disease data collection, we expand our understanding of the common psychiatric manifestations, describe variability in terms of self-care and quality of life, and emphasize potential biomarkers for individuals with SLSMDS. Our study describes how efficient patient-researcher partnerships can develop and sustain novel mechanisms to collect rare disease data, improve our understanding of the natural history of these disorders, and support development of future treatments.

#4

Clinical and Morphological Bone Marrow Characteristics of Pearson Syndrome: About Three Consecutive Cases and Review of the Literature.

Case reports in pediatrics2025

Pearson syndrome (PS) is a rare and fatal multisystem disorder caused by a mitochondrial DNA (mtDNA) deletion. Most patients develop refractory anemia in early infancy, rapidly followed by multiple complications such as failure to thrive, muscle hypotonia, pancreatic insufficiency, and renal tubulopathy. Although the definitive diagnosis is established by mtDNA sequencing, bone marrow (BM) cytology is a cornerstone of diagnosis, typically revealing precursor vacuolization and ring sideroblasts. We report here three cases of patients with PS encountered in our institution and summarize the clinical and hematological features of PS through a systematic review of the literature. The first symptoms mostly appear during the first month of life and rarely after 18 months. Hyporegenerative anemia, a hallmark of the disease, is the most common initial symptom, followed at a distance by neutropenia and thrombocytopenia. Gastrointestinal and metabolic symptoms such as failure to thrive and lactic acidosis are the most frequent non-hematological symptoms, even in the rare cases without hyporegenerative anemia. Vacuolization of BM precursors, observed in the vast majority of PS patient BMAs, is not influenced by the patient's age at sampling. Ring sideroblasts, the other feature of PS BMAs, are less frequent than progenitor vacuolization but increase significantly after 6 months of age. These abnormalities are just as common in patients with or without hematological symptoms, suggesting that BMA should be performed in all suspected PS cases, despite the absence of anemia. PS is a multisystem disorder requiring early diagnosis and a coordinate multidisciplinary management, involving clinicians and clinical biologists.

#5

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases.

Orphanet journal of rare diseases2025 May 17

Endocrine dysfunctions are commonly associated with mitochondrial diseases. This study aimed to investigate clinical characteristics and outcomes of endocrine manifestations in patients with mitochondrial diseases. This study included 54 patients from 47 families with mitochondrial diseases who were genetically confirmed; 49 patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), four with Pearson syndrome, and one with Kearns-Sayre syndrome (KSS). Clinical and endocrine findings were retrospectively reviewed. The median age at diagnosis was 18.5 years (range, 0.1 - 49 years). In 49 patients with MELAS, the mean height and weight standard deviation scores were - 2.0 ± 1.3 and - 2.6 ± 1.6, respectively, with 44.9% (n = 22) of the patients exhibiting short stature at diagnosis. Twenty-three (46.9%) patients with MELAS were diagnosed with diabetes mellitus (DM) at a median age of 26 years (range, 12 - 50 years). Interestingly, papillary thyroid cancer was observed in 10.2% of patients (n = 5) with MELAS at a mean age of 34.1 ± 6.9 years. One patient with MELAS and one with KSS exhibited hypoparathyroidism. Patients with Pearson syndrome and KSS exhibited more severe short stature. Adrenal insufficiency was noted in 50% of the patients with Pearson syndrome. In 20% of patients with MELAS, endocrine dysfunctions including having a short stature, DM, and hypoparathyroidism preceded the onset of neurological manifestations. Papillary thyroid cancer occurred in 10% of patients with MELAS. Patients with Pearson syndrome and KSS showed profound growth retardation and multisystem dysfunctions, such as chronic kidney disease and neurological defects, which contributed to increased mortality.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC93 artigos no totalmostrando 78

2026

Pearson Syndrome: Diagnostic Challenges and a Case of Successful Haploidentical Hematopoietic Stem Cell Transplantation.

Pediatric blood &amp; cancer
2025

Detecting mitochondrial electron transport chain enzyme defects in low-heteroplasmy single large-scale mtDNA deletion syndromes (SLSMDSs).

Molecular genetics and metabolism
2026

Genotype-Phenotype Correlations in Chinese Pediatric Patients With Single Large-Scale Mitochondrial DNA Deletion Disorders.

Clinical genetics
2025

Molecular Aspects of Mitochondrial Dysfunction in Diabetes, Pearson and Kearns-Sayre Syndromes, and Neurodegenerative Disorders.

International journal of general medicine
2025

Pearson syndrome with atypical presentation of short stature and atypical limb proportions - First reported case in Slovakia.

Mitochondrion
2025

Single large-scale mitochondrial DNA deletion syndromes: scientific and family conference optimizes the collection of rare disease research outcomes.

Orphanet journal of rare diseases
2024

Mitophagy modulation rescues single large-scale mitochondrial DNA deletion (SLSMD) disease symptoms in the C. elegans uaDf5 animal model.

bioRxiv : the preprint server for biology
2025

Neuroimaging characteristics of single Large-Scale mitochondrial DNA deletion syndromes.

Neuroradiology
2025

Clinical and Morphological Bone Marrow Characteristics of Pearson Syndrome: About Three Consecutive Cases and Review of the Literature.

Case reports in pediatrics
2025

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases.

Orphanet journal of rare diseases
2025

Post-Transplant Course of Pearson Syndrome.

Pediatric blood &amp; cancer
2025

Single Large-Scale Mitochondrial Deletion Syndromes: Neuroimaging Phenotypes and Longitudinal Progression in Pediatric Patients.

AJNR. American journal of neuroradiology
2025

Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS).

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Study of clinical manifestations and etiologies of megaloblastic anemia in children.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
2024

Primary adrenal insufficiency: case study IN 5 tertiary hospitals.

Anales de pediatria
2025

Long-term hematopoietic dysfunction in patients with large-scale mitochondrial DNA deletion syndromes.

Pediatric blood &amp; cancer
2024

Congenital sideroblastic anemia with vacuolated bone marrow precursors secondary to SLC25A38 mutation-A great mimicker of Pearson syndrome.

International journal of laboratory hematology
2023

Adrenocortical function in patients with Single Large Scale Mitochondrial DNA Deletions: a retrospective single centre cohort study.

European journal of endocrinology
2023

Understanding the impact of pediatric single large-scale mtDNA deletion syndromes on caregivers: Burdens and challenges.

JIMD reports
2024

Atypical presentation of Pearson syndrome in an infant with suspected myelodysplastic syndrome.

Pediatric nephrology (Berlin, Germany)
2023

Pancytopenia and haematopoietic precursor vacuolisation in an infant: Clues to Pearson syndrome.

British journal of haematology
2023

Conduction defects in pediatric patients with Pearson syndrome: When to pace?

Heart rhythm
2023

Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.

BMB reports
2023

Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome.

Pediatric blood &amp; cancer
2023

Phenotyping mitochondrial DNA-related diseases in childhood: A cohort study of 150 patients.

European journal of neurology
2023

Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing.

Critical reviews in clinical laboratory sciences
2023

A Case Report on Pearson Syndrome With Emphasis on Genetic Screening in Patients Presenting With Sideroblastic Anemia and Lactic Acidosis.

Cureus
2023

Adrenal Dysfunction in Mitochondrial Diseases.

International journal of molecular sciences
2022

Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes.

Science translational medicine
2023

B-cell Immunodeficiency in a Patient with Pearson Syndrome.

Journal of clinical immunology
2022

Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure.

Orphanet journal of rare diseases
2022

Pearson syndrome-like anemia induced by accumulation of mutant mtDNA and anemia with imbalanced white blood cell lineages induced by Drp1 deletion in a murine model.

Pharmacological research
2022

Congenital etiologies of exocrine pancreatic insufficiency.

Frontiers in pediatrics
2022

Case Report: Clinical and Genetic Characteristics of Pearson Syndrome in a Chinese Boy and 139 Patients.

Frontiers in genetics
2022

Extremely Rare Case of Fetal Anemia Due to Mitochondrial Disease Managed with Intrauterine Transfusion.

Medicina (Kaunas, Lithuania)
2022

Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome.

Disease models &amp; mechanisms
2022

Clinical and genetic features of four patients with Pearson syndrome: An observational study.

Medicine
2022

Preterm twins with antenatal presentation of Pearson syndrome.

Case reports in perinatal medicine
2021

Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in and out of the liver'.

World journal of hepatology
2023

Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study.

Journal of medical genetics
2021

Pediatric single large-scale mtDNA deletion syndromes: The power of patient reported outcomes.

Molecular genetics and metabolism
2021

Pearson syndrome in a child transplanted for Diamond-Blackfan anemia.

Archivos argentinos de pediatria
2021

In-depth understanding of Pearson syndrome arising from a novel large mitochondrial DNA deletion in an infant case.

Translational pediatrics
2021

Haematological characteristics and spontaneous haematological recovery in Pearson syndrome.

British journal of haematology
2021

De Novo Development of mtDNA Deletion Due to Decreased POLG and SSBP1 Expression in Humans.

Genes
2021

Identification of a novel large deletion of the mitochondrial DNA in an infant with Pearson syndrome: a case report.

Translational pediatrics
2021

A useful method to diagnose Pearson syndrome mimicking Diamond-Blackfan anemia.

Pediatrics international : official journal of the Japan Pediatric Society
2021

Acquisition of monosomy 7 and a RUNX1 mutation in Pearson syndrome.

Pediatric blood &amp; cancer
2020

The Phenotypic Spectrum of 47 Czech Patients with Single, Large-Scale Mitochondrial DNA Deletions.

Brain sciences
2021

Pearson Syndrome: Spontaneously Recovering Anemia and Hypoparathyroidism - Correspondence.

Indian journal of pediatrics
2020

Pearson Syndrome: Spontaneously Recovering Anemia and Hypoparathyroidism.

Indian journal of pediatrics
2020

Propionic acidemia: an extremely rare cause of hemophagocytic lymphohistiocytosis in an infant.

Archivos argentinos de pediatria
2019

Pearson syndrome: a rare inborn error of metabolism with bone marrow morphology providing a clue to diagnosis.

Sudanese journal of paediatrics
2020

Broadening the phenotypic spectrum of Pearson syndrome: Five new cases and a review of the literature.

American journal of medical genetics. Part A
2019

Delayed Onset of Retinopathy of Prematurity Associated With Mitochondrial Dysfunction and Pearson Syndrome.

Journal of pediatric ophthalmology and strabismus
2020

Pearson marrow-pancreas syndrome with cardiac conduction abnormality necessitating prophylactic pacemaker implantation.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2019

[Mitochondrial DNA deletion syndrome: a case report and literature review].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2019

Early diagnosis of Pearson syndrome in neonatal intensive care following rapid mitochondrial genome sequencing in tandem with exome sequencing.

European journal of human genetics : EJHG
2020

Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia.

Journal of pediatric hematology/oncology
2019

Pearson Syndrome: A Rare Cause of Failure to Thrive in Infants.

Clinical pediatrics
2019

Sideroblastic anemia associated with multisystem mitochondrial disorders.

Pediatric blood &amp; cancer
2018

Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2018

Pearson Syndrome, A Medical Diagnosis Difficult to Sustain Without Genetic Testing.

Clinical laboratory
2018

A Novel Mitochondrial DNA Deletion in Patient with Pearson Syndrome.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2018

Endocrine Disorders in Primary Mitochondrial Disease.

Journal of the Endocrine Society
2018

Secondary Hemophagocytic Syndrome Associated with COG6 Gene Defect: Report and Review.

JIMD reports
2018

Bone marrow features in Pearson syndrome with neonatal onset: A case report and review of the literature.

Pediatric blood &amp; cancer
2017

Renal manifestations of primary mitochondrial disorders.

Biomedical reports
2017

An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure.

Blood
2017

[A regenerative anemia in infants: 2 cases of Pearson´s syndrome].

Archivos argentinos de pediatria
2016

An Unusual Case of LCHAD Deficiency Presenting With a Clinical Picture of Hemophagocytic Lymphohistiocytosis: Secondary HLH or Coincidence?

Journal of pediatric hematology/oncology
2016

Fusarium Osteomyelitis in a Patient With Pearson Syndrome: Case Report and Review of the Literature.

Open forum infectious diseases
2016

Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.

European journal of pediatrics
2015

WITHDRAWN: A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.

European journal of medical genetics
2016

Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica).

JIMD reports
2016

A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.

Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis
2015

Redefining phenotypes associated with mitochondrial DNA single deletion.

Journal of neurology
2015

Biochemical abnormalities in Pearson syndrome.

American journal of medical genetics. Part A
Ver todos os 93 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Pearson.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Pearson

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Genotype-Phenotype Correlations in Chinese Pediatric Patients With Single Large-Scale Mitochondrial DNA Deletion Disorders.
    Clinical genetics· 2026· PMID 41074779mais citado
  2. Pearson Syndrome: Diagnostic Challenges and a Case of Successful Haploidentical Hematopoietic Stem Cell Transplantation.
    Pediatric blood &amp; cancer· 2026· PMID 41873175mais citado
  3. Single large-scale mitochondrial DNA deletion syndromes: scientific and family conference optimizes the collection of rare disease research outcomes.
    Orphanet journal of rare diseases· 2025· PMID 40760494mais citado
  4. Clinical and Morphological Bone Marrow Characteristics of Pearson Syndrome: About Three Consecutive Cases and Review of the Literature.
    Case reports in pediatrics· 2025· PMID 40420845mais citado
  5. Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases.
    Orphanet journal of rare diseases· 2025· PMID 40382647mais citado
  6. Detecting mitochondrial electron transport chain enzyme defects in low-heteroplasmy single large-scale mtDNA deletion syndromes (SLSMDSs).
    Mol Genet Metab· 2025· PMID 41086592recente
  7. Molecular Aspects of Mitochondrial Dysfunction in Diabetes, Pearson and Kearns-Sayre Syndromes, and Neurodegenerative Disorders.
    Int J Gen Med· 2025· PMID 40959587recente
  8. Pearson syndrome with atypical presentation of short stature and atypical limb proportions - First reported case in Slovakia.
    Mitochondrion· 2025· PMID 40834967recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:699(Orphanet)
  2. OMIM OMIM:557000(OMIM)
  3. MONDO:0010797(MONDO)
  4. GARD:7343(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q9081107(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Pearson
Compêndio · Raras BR

Síndrome Pearson

ORPHA:699 · MONDO:0010797
Prevalência
<1 / 1 000 000
Casos
194 casos conhecidos
Herança
Mitochondrial inheritance, Not applicable
CID-10
D64.0 · Anemia sideroblástica hereditária
CID-11
Ensaios
2 ativos
Medicamentos
1 registrados
Início
Childhood, Infancy, Neonatal
Prevalência
0.004 (Worldwide)
MedGen
UMLS
C0342784
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades